Worst performer was PAF:Pan African Resources which lost 9% and most of the recent gains. The price action seems very odd on this one, with quite wide swings and an odd spread. I think the general direction is up, and when production starts on the new project I expect a significant re-rate. It remains quite a high risk though.
OPTI:Optibiotix was the second worst performer, dropping 5p which is 8%. It still has a healthy profit, so all we can do is hope the promised Christmas surprise appears next week. If it doesn't, then the Christmas surprise will be that there's no Christmas surprise!
SBTX:SkinBioTherapeutics dropped 5% and is now in prime territory for a purchase. My initial plan for spending the £2,000 I'm transferring from my work pension to my SIPP was to split it between here and MTFB:Motif Bio, but I already have a big chunk invested in MTFB:Motif Bio, and if the FDA doesn't approve their application it will be wiped out, so I may pile all £2,000 into SBTX:SkinBioTherapeutics at this price.
IQE:IQE is still struggling horribly and dropped another 5%, as did WRES:W Resources, which is surprising now they've started production. I was expecting a little spike so I could get rid of the damn things.
CEY:Centamin had a good week, climbing 5% in my SIPP and 7% of purchase price in my trading account. These will re-rate, I have no doubt.
RED:RedT Energy has been struggling lately, with doubts they can make enough on each unit to get into profit. However, the price recovered by 8% this week but is still 48% down on purchase price.
AMYT:Amryt Pharma has really fallen out of favour lately, but climbed 8% this week. It's only 23% down now, and I really don't understand why it's down at all. A trading update would be useful as they must be raking in the cash now.
Share of the Week is TAP:Taptica, which after a 40% drop last week on the resignation of their CEO, climbed 10% this week. It will get back into profit, but when it does I won't be hanging around as long as I did last time it was in profit - I must remember, this is in what's meant to be my trading account.
Only slightly in the red, so looks as if it's just touching the line.
Here's the ISA and share portfolios
| Weekly Change | |||
| Cash | £30.05 | +£0 | |
| Portfolio cost | £56,958.55 | +£0 | |
| Portfolio sell value (bid price - commission) | £55,237.69 | (-3%) | -£2,517.67 |
| Potential profits | £8,837.13 | -£2,529.80 | |
| Yr 4 Dividends | £60.50 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £195.29 | (4.1%) | -£10.85 |
| Total Dividends | £1,298.83 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £511.21 | (10.8%) | -£2.94 |
| (Sold stocks profit + Dividends - Fees / Months) |
Woohoo - £10 less drop in value compared to potential profit - so I clawed back £10 of my losses this week! Nothing else happened.
Back into negative territory
The SIPP looks like this after week 159
| Weekly Change | |||
| Cash | £138.64 | +£0 | |
| Portfolio cost | £35,825.45 | +£0 | |
| Portfolio sell value (bid price - commission) | £37,682.05 | (5.2%) | -£1,570.36 |
| Potential profits | £5,915.24 | -£1,338.78 | |
| Yr 4 Dividends | £0 | +£0 | |
| Yr 4 Interest | £0 | +£0 | |
| Yr 4 Profit from sales | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Total Dividends | £1,342.25 | +£0 | |
| Total Interest | £0.03 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £316.50 | (10.6%) | -£2.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Losses deepened by an extra £430 on top of my reduction in potential profit. Nothing else happened, but it will next week!
Still a decent buffer on this account.
The trading portfolio looks like this after week 125
| Weekly Change | |||
| Cash | £18.80 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,399.57 | (-39.7%) | +£21.41 |
| Potential profits | £0 | +£0 | |
| Year 3 Dividends | £17.33 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £40.11 | (20.7%) | -£2.01 |
| Dividends | £18.48 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£1.59 | (-0.8%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Stunning - it's actually gone up! Mainly thanks to a small recovery from CAML:Central Asia Metals and TAP:Taptica climbing 10%. Other losses meant the climb wasn't very much.
Still bobbins
So, it's the last week before Christmas and the last week for OPTI:Optibiotix to deliver the promised Christmas surprise. Lets hope it materialises and can get the portfolio back in the black. In the meantime, it's 10 days since I requested my pension transfer, so I'd better have £2,000 to spend in my SIPP or I'll be terribly, terribly vexed.
No comments:
Post a Comment